tiprankstipranks
bioAffinity Technologies, Inc. (BIAF)
NASDAQ:BIAF
US Market
Holding BIAF?
Track your performance easily

bioAffinity Technologies, Inc. (BIAF) Financial Statements

49 Followers

bioAffinity Technologies, Inc. Financial Overview

bioAffinity Technologies, Inc.'s market cap is currently ―. The company's EPS TTM is $-0.801; its P/E ratio is -1.54; bioAffinity Technologies, Inc. is scheduled to report earnings on March 28, 2025, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 2.35M$ 2.40M$ 2.41M$ 2.21M$ 298.48K
Gross Profit$ 2.35M$ 2.40M$ 2.41M$ 548.50K$ 223.78K
EBIT$ -1.98M$ -2.08M$ -1.93M-$ -2.28M
EBITDA$ -1.83M$ -1.93M$ -1.78M-$ -2.22M
Net Income Common Stockholders$ -2.00M$ -2.11M$ -1.96M$ -2.37M$ -2.29M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 800.00K$ 800.00K$ 2.50M$ 2.80M$ 4.50M
Total Assets$ 6.55M$ 6.66M$ 8.05M$ 8.22M$ 10.19M
Total Debt$ 1.72M$ 1.38M$ 1.49M$ 1.58M$ 1.69M
Net Debt$ 919.40K$ 580.00K$ -1.01M$ -1.22M$ -2.81M
Total Liabilities$ 3.43M$ 3.22M$ 2.79M$ 3.37M$ 3.20M
Stockholders Equity$ 3.12M$ 3.43M$ 5.22M$ 4.86M$ 6.99M
Cash Flow-
Free Cash Flow$ -1.72M$ -1.56M$ -2.39M-$ -1.53M
Operating Cash Flow$ -1.71M$ -1.53M$ -2.35M$ -1.62M$ -1.53M
Investing Cash Flow$ -9.41K$ -28.29K$ -41.39K$ 13.44K$ -2.19M
Financing Cash Flow$ 1.67M$ -91.14K$ 2.02M$ -84.81K$ -50.77K
Currency in USD

bioAffinity Technologies, Inc. Earnings and Revenue History

bioAffinity Technologies, Inc. Debt to Assets

bioAffinity Technologies, Inc. Cash Flow

bioAffinity Technologies, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis